Kopran Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Net profit of Kopran rose 94.94% to Rs 18.87 crore in the quarter ended March 2026 as against Rs 9.68 crore during the previous quarter ended March 2025. Sales rose 35.77% to Rs 234.02 crore in the quarter ended March 2026 as against Rs 172.36 crore during the previous quarter ended March 2025.

For the full year,net profit declined 33.26% to Rs 25.73 crore in the year ended March 2026 as against Rs 38.55 crore during the previous year ended March 2025. Sales rose 8.23% to Rs 681.42 crore in the year ended March 2026 as against Rs 629.60 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Kopran announced that the Board of Directors of the Company at its meeting held on 19 May 2026, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.

Kopran will hold a meeting of the Board of Directors of the Company on 19 May 2026.

Kopran announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 3 June 2026.